Q-REstrain Gene Therapy
A Personalised RNA-Based Supportive Approach in Integrative Oncology
What is Q-REstrain Gene Therapy ?
Advanced microRNA for Cancer
Autologous Therapy
Q-REstrain Gene Therapy
At Stem Cell Center Malaysia, we understand that cancer is driven not only by abnormal cells, but by abnormal signals inside those cells that promote tumour growth, survival, and resistance to treatment.
Q-REstrain Gene Therapy is a personalised, RNA-based supportive approach designed to help reduce the production of cancer-related proteins by regulating these abnormal molecular signals. It works through a natural biological mechanism known as RNA interference (RNAi).
Q-REstrain Gene Therapy is offered strictly as a supportive, adjunctive option and is not a replacement for surgery, chemotherapy, radiotherapy, immunotherapy, or any treatment prescribed by an oncologist.
Why Protein Production Is Important in Cancer
Cancer cells behave differently from normal cells because they produce excessive or abnormal proteins that help them:
-
Grow and divide uncontrollably
-
Avoid normal cell death
-
Resist treatment
-
Suppress immune recognition
-
Create a supportive tumour environment
These proteins are made based on genetic instructions inside the cell. When those instructions are overactive or faulty, cancer progression is encouraged.
In many cancers, the issue is not only the cancer cell itself, but the continuous production of proteins that support tumour growth and survival.
Understanding RNA Interference (RNAi)
RNA interference (RNAi) is a naturally occurring process used by the body to regulate which proteins are produced and in what amount.
To understand RNAi, it helps to know how proteins are made:
-
DNA stores genetic information
-
Messenger RNA (mRNA) carries instructions from DNA
-
Cells use mRNA to produce proteins
In cancer cells, certain mRNA messages are over-expressed, leading to excessive production of proteins that support cancer progression.
RNAi works by stopping harmful messages before proteins are made
RNA interference:
-
Identifies specific cancer-related mRNA messages
-
Breaks down those messages
-
Prevents the corresponding cancer-related proteins from being produced
No message means reduced production of harmful cancer-associated proteins
This RNA-based strategy is widely studied and used in modern cancer research and targeted cancer therapies.
How Q-REstrain Gene Therapy Applies RNAi in Cancer Support
Q-REstrain™ Therapy applies RNA interference in a personalised and autologous manner, meaning it is created using material derived from the patient’s own biological sample.
The process, step by step:
-
Patient-derived sample
MicroRNA molecules are isolated from the patient’s own sample. -
Identification of cancer-related signals
Specific mRNA signals that are over-expressed and linked to cancer activity are identified. -
Targeted microRNA action
These microRNAs bind to the identified mRNA messages. -
Reduction of cancer-related protein production
By degrading these messages, the production of proteins associated with tumour growth and survival is reduced. -
Support toward regulated gene expression
This helps support a shift toward more controlled and balanced cellular signalling.
Q-REstrain™ Therapy does not destroy cancer cells directly.
It works by reducing the molecular signals that support cancer progression.
Integration with Supportive & Cellular-Based Cancer Approaches
Where clinically appropriate and subject to regulatory compliance, Q-REstrain™ Therapy may be considered alongside:
-
Personalised nutrition and detoxification strategies
To support metabolic balance, inflammation control, and overall resilience during cancer care. -
High-dosage selected vitamin protocols (medically supervised)
Prescribed based on clinical judgement to support immune and cellular health. -
Autologous Natural Killer (NK) Cell-based therapies
Immune-supportive approaches using the patient’s own NK cells, within approved clinical frameworks. -
CAR-T Cell Therapy (externally coordinated where indicated)
Coordinated with licensed oncology centres when clinically appropriate.
Q-REstrain™ Therapy functions as a molecular signal-modulating support, not as a replacement for standard cancer treatment.
Key Characteristics of Q-REstrain Gene Therapy
-
Autologous – derived from the patient’s own biological material
-
Non-manipulated – no genetic modification
-
Highly personalised – uniquely created for each patient
-
Supportive, not curative – complements oncological care
-
Non-cytotoxic – does not rely on cell destruction
Q-REstrain™ Therapy is available exclusively through the RGCC network and is offered only following appropriate medical assessment.
Clinical Context & Intended Role in Cancer Care
Q-REstrain™ Therapy may be considered as a supportive integrative option for cancer patients who:
-
Are undergoing conventional cancer treatment
-
Are in post-treatment monitoring or maintenance phases
-
Have recurrent or treatment-resistant cancers (case-dependent)
-
Seek a targeted, non-aggressive molecular support approach
Suitability is determined on a case-by-case basis through medical consultation.
Why Choose Stem Cells Center?
At Stem Cells Center, we combine 30 years of regenerative medicine experience with world-class facilities in Malaysia and Switzerland. Here’s what sets us apart:
- ✔️ Medical-grade stem cells, cultured under GMP standards
- ✔️ Customized treatment plans guided by our expert team
- ✔️ Non-invasive IV infusions and optional localized injections
- ✔️ Post-treatment monitoring for real-time outcome tracking
- ✔️ Trusted by international patients from Malaysia, Indonesia, and beyond
Our goal is to help you regain control of your health—naturally, safely, and effectively.
